These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5493532)

  • 1. Inhibitors of the fibrinolytic enzyme system in renal disease.
    Bennett NB; Ogston D
    Clin Sci; 1970 Nov; 39(5):549-57. PubMed ID: 5493532
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity.
    Hedner U; Nilsson IM; Jacobsen CD
    Scand J Clin Lab Invest; 1970 Jun; 25(4):329-36. PubMed ID: 4247664
    [No Abstract]   [Full Text] [Related]  

  • 3. On coagulation and fibrinolysis in renal failure.
    Larsson SO
    Scand J Haematol Suppl; 1971; 15():1-59. PubMed ID: 5284430
    [No Abstract]   [Full Text] [Related]  

  • 4. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects.
    Thorsen S
    Scand J Clin Lab Invest; 1973 Jan; 31(1):51-9. PubMed ID: 4687777
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum and urinary lysozyme activities in patients with renal diseases.
    Niwa T; Ito T; Matsui E; Ota H
    Tohoku J Exp Med; 1974 Sep; 114(1):27-33. PubMed ID: 4432241
    [No Abstract]   [Full Text] [Related]  

  • 6. Resting levels of fibrinolysis in blood in inactive and exercising men.
    Moxley TR; Brakman P; Astrup T
    J Appl Physiol; 1970 May; 28(5):549-52. PubMed ID: 5442247
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical study on urinary kallikrein in patients with renal diseases.
    Kimura K; Onodera K; Oike Y; Yamabe H; Numahata H; Kikuchi K; Hanada S
    Adv Exp Med Biol; 1979; 120B():549-59. PubMed ID: 517249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urokinase excretion and fibrinolysis in infectious kidney diseases].
    Bachmann HJ; Tacke E; Haupt H
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):567-8. PubMed ID: 4411414
    [No Abstract]   [Full Text] [Related]  

  • 9. [Additional potentials of a method of standard fibrin plates].
    Kovalenko AN
    Lab Delo; 1980; (10):615-8. PubMed ID: 6158612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract]   [Full Text] [Related]  

  • 11. Previously undescribed fibrinolysis inhibitor in human blood.
    Siegel-Ralston A; Astrup T
    Nat New Biol; 1971 Dec; 234(49):180-1. PubMed ID: 4257614
    [No Abstract]   [Full Text] [Related]  

  • 12. Pattern of the activator inhibitor in carcinoma and renal diseases.
    Hedner U; Nilsson IM
    Scand J Haematol; 1973; 11(5):398-404. PubMed ID: 4798342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of components of the fibrinolytic system in healthy children].
    Sofronova LV
    Vopr Okhr Materin Det; 1975 Jun; 20(6):17-9. PubMed ID: 124506
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary tissue plasminogen activator in renal disease.
    Heussen-Schemmer C; Barron JR; Swanepoel CR; Dowdle EB
    Nephron; 1993; 64(1):42-6. PubMed ID: 8502335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gamma-glutamyl transpeptidase activities in 24-hour urine in various forms of kidney disease (author's transl)].
    Bahre G; Kley R; Brass H
    Dtsch Med Wochenschr; 1974 Nov; 99(44):2214-8. PubMed ID: 4154192
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of plasminogen activators by naturally occurring inhibitors in man.
    Aoki N; Kawano T
    Am J Physiol; 1972 Dec; 223(6):1334-7. PubMed ID: 4641625
    [No Abstract]   [Full Text] [Related]  

  • 18. Lactic dehydrogenase in kidney tissue and renal disease. Adaptive change of the synthesis in acute failure.
    Nielsen VK; Kemp E; Laursen T
    Acta Med Scand; 1968; 184(1-2):109-19. PubMed ID: 5703958
    [No Abstract]   [Full Text] [Related]  

  • 19. Alkaline phosphatase activity in leukocytes of patients with renal failure treated with dialyses.
    Kuska J
    Pol Med J; 1971; 10(3):570-6. PubMed ID: 5124125
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lipase activity in chronic renal failure.
    Sommer H; Kasper H; Fösel T
    Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):248-52. PubMed ID: 1179947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.